In November 2023, the prices of Amoxicillin Trihydrate showed a downward trend in the USA and Germany markets. The reasons responsible for this trend include sluggish trading activities, lower crude oil prices, and fewer inquiries for Amoxicillin Trihydrate from downstream industries. Due to a lack of substantial orders and intense market competition, the supply of Amoxicillin Trihydrate in the market was abundant, which prompted market players to offer lower quotations.

China primarily supplies Active Pharmaceutical Ingredients (APIs) to the USA and European markets. Recent data reveals a contraction in China's manufacturing activity for the second consecutive month in November, signifying a slowdown in the world's second-largest economy despite heightened government efforts to stimulate growth. According to the NBS, the official manufacturing PMI unexpectedly decreased slightly from 49.5 in October to 49.4 in November. These statistics underscore the persisting challenge of insufficient market demand, notably impacting the ongoing recovery and advancement of the manufacturing sector, which subsequently affected the Amoxicillin Trihydrate market. Furthermore, the Chinese domestic market cannot compensate for the losses witnessed in Europe and the United States. The sub-index for new orders experienced a contraction for the second straight month, and the component for new export orders continued its decline for the ninth consecutive month. These trends indicate an escalating downward pressure on foreign demand, as reflected in the decrease in the export orders component, contributing to the overall downward trajectory of Amoxicillin Trihydrate prices in the USA and Germany.

Moreover, recent data indicates a general decrease in global crude oil prices, influenced by heightened supply from non-OPEC nations and an easing of tensions in the Middle East. Consequently, this has reduced transportation costs and business expenditures, adding to the overall decline in prices for Amoxicillin Trihydrate.

In November, the US Federal Reserve announced its decision to keep the benchmark interest rate steady at 5.25% to 5.50%. This marks the second consecutive meeting where the central bank has chosen to maintain the existing monetary policy, putting additional pressure on consumer spending and consequently causing a decrease in prices for Amoxicillin Trihydrate in the USA. Similarly, Germany, Europe's largest economy, experienced a decline in annual inflation to 2.3% this month from 3% in October. This new figure closely aligns with the European Central Bank's inflation target of 2%, a result of a series of rapid interest rate hikes that continue to constrain consumers' purchasing power and contribute to the decline in Amoxicillin Trihydrate prices in Germany.

According to ChemAnalyst's analysis, there is an anticipated increase in the prices of Amoxicillin Trihydrate in the coming months, attributed to growing demand from end-user healthcare and pharmaceutical sectors. With the onset of winter, it is expected that fever and cold may escalate, potentially boosting the demand for antibiotics and subsequently causing an upturn in Amoxicillin Trihydrate prices.